What Are the Results of the REVIVE-2 Trial?

Video
Conference|ID Week

David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.

David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.

Recent Videos
Related Content
Over 3 Million Children Died From AMR-Linked Infections in 2022

Over 3 Million Children Died From AMR-Linked Infections in 2022

Sophia Abene
April 15th 2025
Article
From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc ;Jose Alexander, MD, ABMM, ABAIM, FCCM, CIC, ASCP, BCMAS
December 23rd 2024
Podcast
Top 5 HIV Stories from CROI 2025: New Treatments, HIV Remission Insights, and More

Top 5 HIV Stories from CROI 2025: New Treatments, HIV Remission Insights, and More

Sophia Abene
March 21st 2025
Article
From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
August 1st 2024
Podcast
Ensitrelvir Prevents COVID-19 Infection as Post Exposure Prophylaxis

Ensitrelvir Prevents COVID-19 Infection as Post Exposure Prophylaxis

John Parkinson
March 13th 2025
Article
Exploring Novel Dosing Strategies by Reducing Once Daily Biktarvy

Exploring Novel Dosing Strategies by Reducing Once Daily Biktarvy

John Parkinson
March 11th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.